For research use only. Not for therapeutic Use.
Vilanterol trifenatate(CAT: I010030) is a long-acting beta2-adrenergic agonist (LABA) used as a bronchodilator in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is often formulated in combination with an inhaled corticosteroid for the management of these respiratory conditions. Vilanterol acts by stimulating beta2-adrenergic receptors in the smooth muscles of the airways, resulting in relaxation and widening of the bronchial passages. This helps to relieve bronchospasm and improve airflow, making breathing easier for individuals with asthma or COPD.
| Catalog Number | I010030 |
| CAS Number | 503070-58-4 |
| Synonyms | GW-642444; GW642444; GW-642444; GW 642444X; Vilanterol; Vilanterol trifenatate.;4-{(1R)-2-[(6-{2-[(2,6-Dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
| Molecular Formula | C24H33Cl2NO5 |
| Purity | ≥95% |
| Target | Adrenergic Receptor |
| Solubility | Soluble in DMSO. |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| IUPAC Name | 4-[(1S)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;2,2,2-triphenylacetic acid |
| InChI | InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m1./s1 |
| InChIKey | KLOLZALDXGTNQE-GJFSDDNBSA-N |
| SMILES | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl |
| Reference | <br /> |
